�•‹³�E“cŒû�@—S
�¶‚¢—§‚¿1979”N�¶‚Ü‚ê
2003”N3ŒŽ �é‹Ê‘åŠw —�Šw•” •ªŽq�¶•¨Šw‰È ‘²‹Æ
2005”N3ŒŽ “Œ‹ž‘åŠw‘åŠw‰@ ”_Šw�¶–½‰ÈŠwŒ¤‹†‰È ‰ž—p�¶–½�HŠw�ê�U �CŽm‰Û’ö �C—¹
2009”N3ŒŽ “Œ‹ž‘åŠw‘åŠw‰@ ˆãŠwŒnŒ¤‹†‰È •ªŽq�×–E�¶•¨Šw�ê�U ˆãŠw”ŽŽm‰Û’ö �C—¹
2009”N4ŒŽ “Œ‹ž‘åŠwˆã‰ÈŠwŒ¤‹†�Š•ªŽq”Šà•ª–ì “Á”CŒ¤‹†ˆõ
2012”N5ŒŽ “Œ‹ž‘åŠwˆã‰ÈŠwŒ¤‹†�Š•ªŽq”Šà•ª–ì �•‹³
Žï–¡
ƒoƒŒ�[ƒ{�[ƒ‹
—�”O
�s“®
‹Æ�Ñ
- Taguchi, Y., Kiga, Y., Gohda, J. and Inoue, J. Identification and characterization of anti-osteoclastogenic peptides derived from the cytoplasmic tail of RANK. J. Bone Miner. Metab. in press (2012)
- Taguchi,Y., Gohda, J., Koga,T., Takayanagi, H., and Inoue, J.
A unique domain in RANK is required for Gab2 and PLCƒÁ2 binding to establish osteoclastogenic signals.
Genes Cells., 14(11):1331-45. (2009) - ‘æ27‰ñ “ú–{�œ‘ãŽÓŠw‰ïŠw�p�W‰ï�u—D�Gƒ|ƒXƒ^�[‰‰‘è�Ü�v(2009”N“x)
- ‘æ8‰ñ‚ª‚ñ“Á’è—̈挤‹†�EŽáŽèŒ¤‹†ŽÒƒ��[ƒNƒVƒ‡ƒbƒv�u�Å—D�G�Ü�v(2007”N“x)